| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.19 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.12 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.084 | 0.3 |